Soremekun et al. report the impact of extending seasonal malaria chemoprevention (SMC) to children aged 0–9 years on malaria transmission in the context of a national routine programme. This SMC extension to older children reduces the risk of clinical malaria and asymptomatic infection among adolescents and adults within the same household.
- Seyi Soremekun
- Bakary Conteh
- Chris Drakeley
